Pediatric cancer recurrence poses a significant challenge for healthcare providers and families alike, particularly in cases involving brain tumors like gliomas.Recent advancements in artificial intelligence (AI) in healthcare have highlighted the potential for improved cancer relapse prediction, as evidenced by a groundbreaking study at Mass General Brigham.